Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS??? EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE NON-CONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-controlling Interests
Redeemable non-controlling interests, beginning balance at Dec. 31, 2024 $ 2,463                  
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Accretion of tax equity financing fees 27                  
Net (loss) income (524)                  
Redeemable non-controlling interests, ending balance at Mar. 31, 2025 1,966                  
Beginning balance (in shares) at Dec. 31, 2024       34,501,213 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2024                 2,101,835  
Beginning balance at Dec. 31, 2024 1,045,149     $ 3 $ 2 $ 378,321 $ 652,561 $ (5,874) $ (11,788) $ 31,924
Derivatives Designated as Hedging Instruments:                    
Exercise of stock options (in shares)       70,178            
Exercise of stock options 430         430        
Stock-based compensation expense 2,844         2,844        
Restricted stock units released (in shares)       32,190            
Unrealized gain (loss) from interest rate hedges, net (502)             (502)    
Foreign currency translation adjustment 1,407             1,441   (34)
Accretion of tax equity financing fees (27)           (27)      
Contributions from NCI 2,863                 2,863
Distributions to NCI (1,004)                 (1,004)
Net (loss) income (5,082)           (5,483)     401
Ending balance (in shares) at Mar. 31, 2025       34,603,581 18,000,000          
Treasury stock, ending balance (in shares) at Mar. 31, 2025                 2,101,835  
Ending balance at Mar. 31, 2025 1,046,078     $ 3 $ 2 381,595 647,051 (4,935) $ (11,788) 34,150
Redeemable non-controlling interests, beginning balance at Dec. 31, 2025 1,419                  
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Accretion of tax equity financing fees 46                  
Redeemable non-controlling interests, ending balance at Mar. 31, 2026 $ 1,465                  
Beginning balance (in shares) at Dec. 31, 2025   34,861,428 18,000,000 34,861,428 18,000,000          
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 2,101,835               2,101,835  
Beginning balance at Dec. 31, 2025 $ 1,122,816     $ 3 $ 2 395,656 696,737 (460) $ (11,788) 42,666
Derivatives Designated as Hedging Instruments:                    
Exercise of stock options (in shares)       40,645            
Exercise of stock options 455         455        
Stock-based compensation expense 4,176         4,176        
Restricted stock units released (in shares)       37,344            
Unrealized gain (loss) from interest rate hedges, net 53             53    
Foreign currency translation adjustment (1,892)             (1,917)   25
Accretion of tax equity financing fees (46)           (46)      
Distributions to NCI (1,210)                 (1,210)
Net (loss) income $ (14,383)           (18,283)     3,900
Ending balance (in shares) at Mar. 31, 2026   34,939,417 18,000,000 34,939,417 18,000,000          
Treasury stock, ending balance (in shares) at Mar. 31, 2026 2,101,835               2,101,835  
Ending balance at Mar. 31, 2026 $ 1,109,969     $ 3 $ 2 $ 400,287 $ 678,408 $ (2,324) $ (11,788) $ 45,381